Oxidative stress-induced cytotoxicity of HCC2998 colon carcinoma cells by ZnO nanoparticles synthesized from Calophyllum teysmannii Authors: Hemaroopini Subramaniam, Chan Kiang Lim, Lai Hock Tey, Ling Shing Wong, Sinouvassane Djearamane Published: 2024 ABSTRACT The field of green synthesis, namely using plant extracts for the production of metal nanoparticles, is rapidly gaining traction. Therefore, this study investigated the process of producing zinc oxide nanoparticles (ZnO NPs) using a water-based extract derived from the stem bark of Calophyllum teysmannii. Notably, this is the first documented utilization of this particular plant source. The presence of a distinct Ultraviolet-Visible (UV-Vis) absorption peak at 372 nm provided evidence for the creation of ZnO nanoparticles. The X-ray Diffractometer (XRD) and Field Emission Scanning Electron Microscopy (FESEM) investigations indicated that the nanoparticles exhibited sizes ranging from 31.5 to 59.9 nm and had spherical morphologies. Energy Dispersive X-ray Diffractometer (EDX) analysis verified the elemental composition of the ZnO nanoparticles, whereas the Fourier Transform Infrared (FTIR) spectra showed clear peaks, demonstrating their production. The FTIR examination of the C. teysmannii extract revealed peaks at around 3370 cm− 1, indicating the presence of phenolic compounds. These chemicals are likely responsible for the reduction and stabilization of the ZnO NPs. The high-resolution X-ray Photoelectron Spectroscopy (XPS) spectra clearly revealed separate peaks corresponding to Zn 2p and O 1s, providing confirmation of the chemical states and bonding contexts. The Raman Spectroscopy analysis revealed a distinct peak at around 425 cm⁻¹, confirming the presence of the wurtzite structure. The harmful effects of ZnO nanoparticles on HCC2998 (a kind of human colon cancer) and Vero (a type of monkey kidney epithelial) cells were evaluated using 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT), dichlorodihydrofluorescein diacetate (DCFH-DA), and boron-Dipyrromethene (BODIPY) assays. The cancer cells underwent cell death due to oxidative stress in a dose-dependent manner, as confirmed by microscopic and flow cytometry investigations. Introduction Nanotechnology addresses the advancement and use of materials with diameters ranging up to 100 nm1. Nanotechnology has advanced significantly in recent decades, owing primarily to the extensive use of metal oxide nanoparticles in a variety of industries2,3. The distinctive characteristics of nanomaterials, which are dependent on their size, make them outstanding and essential in several human endeavours, including material science, agriculture, cosmetic items, food processing, pharmaceuticals, and diagnostics. In addition, these particles demonstrate enhanced stability at high temperatures and pressures. Some of these particles are acknowledged for their lack of toxicity and their incorporation of crucial mineral components that are necessary for human physiological processes. Nanotechnology has contributed hugely to the diagnosis and treatment of cancer, which includes drug delivery and carriage, gene and targeted therapy, detection and diagnosis, biomarker mapping, and molecular imaging4. Cancer is marked by the uncontrolled proliferation and dissemination of abnormal cells, which can ultimately result in mortality. Contributing factors to this disease include infectious agents, tobacco use, lifestyle choices, hormonal influences, hereditary genetic mutations, and immune system disorders. These factors may work together or in succession to cause cancer which is treated conventionally via surgery, chemotherapy, and radiation5. According to the statistics, colon cancer is the fifth most common and deadly cancer, worldwide causing more than 1 million new cases and 570,000 new deaths6. Despite the wide array of available anticancer drugs and treatments, a pressing need for therapies that are less toxic and have reduced negative impacts on patients exists. Therefore, it is essential to explore novel approaches that target cancer cells specifically, while sparing normal healthy cells, thereby minimizing undesirable side effects. Zinc oxide (ZnO) stands out among zinc-based nanostructures due to its versatility, environmental friendliness, and diverse physicochemical properties. ZnO nanoparticles (ZnO NPs) are biocompatible and safe for in vivo use, offering broad applications7. Traditional synthesis methods like sol-gel, infrared irradiation, and chemical vapor deposition are costly and environmentally harmful8, necessitating the development of greener alternatives. Green synthesis, using natural resources like plant extracts and microorganisms, avoids harmful by-products and supports sustainable practices. Plant leaf extracts are particularly effective, as their phytochemicals—such as flavones, ketones, terpenoids, aldehydes, amides, and carboxylic acids—serve as both reducing and stabilizing agents in nanoparticle synthesis9. These extracts facilitate a rapid, efficient, and stable formation of metal and metal oxide nanoparticles, making them a valuable resource in green synthesis10,11. The extensive historical use of Calophyllum species in traditional medicine has captivated researchers, prompting them to investigate the substances originating from this genus. The identification of novel chemicals derived from different species of Calophyllum has expanded the range of chemical variety, leading to further investigations into their possible biological impacts. These bioactive compounds, including flavonoids, coumarins, xanthones, and chromanones, have demonstrated diverse biological properties such as anti-tumor, cytotoxic, antimalarial, and antibacterial effects12. However, despite extensive research on the medical applications of ZnO NPs, there are currently no reports on the use of Calophyllum species for the green synthesis of ZnO NPs and cytotoxicity on HCC2998 cell lines. Hence, this research aimed to develop a green synthesis method for ZnO NPs using Calophyllum species extracts and evaluate their cytotoxic effects on HCC2998 colon cancer cells. The nanoparticles were characterized using SEM, EDX, FTIR, UV-Vis, XRD, XPS, and Raman spectroscopy. Cytotoxicity was assessed with a focus on understanding mechanisms such as apoptosis induction and oxidative stress. This study addresses a critical knowledge gap and explores the therapeutic potential of Calophyllum-synthesized ZnO NPs. Materials and methods Materials The stem bark of C. teysmannii used in this study was obtained from Landeh, Sarawak and verified by Mr. Tinjan Anak Kuda, a botanist from the Forest Department of Sarawak. The voucher specimen (UITM 3006) was deposited at the herbarium of Universiti Teknologi MARA, Sarawak. Zinc nitrate hexahydrate [Zn(NO3)2.6H2O] used as the precursor salt was obtained from Uni-Chem® Chemical Reagents, Lahore. Preparation of C. teysmannii stem bark extract Dried and coarsely ground stem bark of C. teysmannii (20 g) was subjected to aqueous extraction by soaking them in 400 mL deionized water for 45 min at 60 °C with continuous stirring. Once cooled, the solution was then passed through a filter paper and the filtrate was then subjected to phytochemical analyses and green synthesis of ZnO NPs13. Phytochemical analyses of C. teysmannii stem bark extract The phytochemical screening of the extracts was conducted with adaption to standard procedures described by Nortjie et al.14. Test for Phenol 1 mL of plant extract was added with 2 mL of 2% FeCl3 solution. The formation of dark green or black colouration confirmed the presence of phenols. Test for Saponin 1 mL of plant extract was added to 5 mL of distilled water and then shaken vigorously. The observation of stable foam formation suggested the presence of saponins. Test for Flavonoid 5 drops of 0.1 M hydrochloric acid (HCl) were added to 1 mL of plant extract. The formation of a dark orangish-red colour confirmed the presence of flavonoids. Test for Tannin 3 drops of 5% of FeCl3 solution were added to 1 mL of plant extract. A greenish-black precipitate confirmed the presence of tannins. Test for Quinone 5 drops of concentrated sulphuric acid (H2SO4) were added to 1 mL of extract. No colour change was observed, indicating the absence of quinones. Test for Coumarin 10% of 1 mL sodium hydroxide (NaOH) was added to 2 mL of extract. The development of yellow colour confirmed the presence of coumarins. Green synthesis of ZnO NPs 100 mL of an aqueous extract of C. teysmannii stem bark was mixed with 6 g of Zn(NO3)2•6H2O. The mixture was then heated to 60 °C and agitated for a duration of 2 h. The solution obtained was subjected to centrifugation at a speed of 12,000 revolutions per minute for a duration of 30 min in order to gather the ZnO NPs pellet. Subsequently, the pellet was meticulously rinsed several times with deionised water. The pellet that was produced underwent calcination at a temperature of 400 °C for a duration of 2 h15. The calcined zinc oxide nanoparticles, acquired as a finely ground pale white substance, were preserved in a cold and dry setting for future use. Characterization of ZnO NPs UV-Vis spectroscopy (UV-Vis) Absorption spectra were analyzed utilizing a UV-visible (UV-Vis) spectrophotometer (GENESYS 10 S, Thermo Scientific, United States)16. X-Ray diffraction (XRD) X-ray powder diffraction (XRD) patterns were collected in the reflection mode with Cu Kα (λ = 1.5406 Å) radiation across the 2θ range of 1 to 80, using X-ray diffractometer (XRD6000, Japan) with continuous scanning operating at 40 kV/30 mA and 0.02 min− 117. Field Emission Scanning Electron microscope (FESEM) and Energy Dispersive X-ray (EDX) Field emission scanning electron microscope (FESEM) (JEOL JSM-6701 F, Japan) in combination with energy dispersive X-ray (EDX) analyzer (X-max, 150 Oxford Instruments, United Kingdom) was employed to study the structural and elemental constituents of the synthesized ZnO NPs17. Fourier transform infrared spectroscopy (FTIR) The infrared spectra were acquired using a FTIR spectrophotometer (2000-FTIR, Perkin Elmer, United States of America)16. X-ray photoelectron spectroscopy (XPS) The ZnO NPs underwent analysis by X-ray photoelectron spectroscopy (XPS) (AXIS Ultra equipped with DLD, Kratos Analytical, United Kingdom)18. Raman spectroscopy Raman spectra were obtained using a micro-Raman spectrometer with an optical microscope (BX51, Olympus, Japan), a CW 532 nm DPSS (diode-pumped solid-state) laser, a CCD camera (DV401, Andor Technology, United Kingdom), and a monochromator (MS257, Oriel Instruments Co., California)18. Antiproliferative analysis Cell culture Human colon carcinoma cells, HCC2998 (CVCL_1266) were obtained from Monash University Malaysia while monkey kidney epithelial cells, Vero (CCL-81) were obtained from Universiti Tunku Abdul Rahman, Malaysia. Both cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM). The cell lines are cultured in the medium added with 10% Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin. These cultures are then maintained at a temperature of 37 °C in an incubator with a 5% CO2 atmosphere (Memmert, Germany)19. MTT Assay The protocol as outlined by Bradshaw19and Leong et al.20 was adapted to conduct the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells were plated in 96-well plates at a density of 1 × 104 cells per well. The synthesized ZnO NPs, along with positive controls; DMSO, and doxorubicin hydrochloride (1.57, 3.13, 6.25, 12.50, 25.00, 50.00 and 100.00 µg/mL) (Nacalai Tesque, Japan), were added to their respective wells and then incubated for 24, 48 and 72 h at 37 ºC in a 5% CO2 incubator. Subsequently, MTT reagent (5 mg/mL) (Invitrogen, Molecular Probes Inc., United States of America) was added and further incubated for 4 hours, and then added with 100 µL of DMSO. Absorbance readings were taken using a microplate reader (Omega, BMG Labtech, Germany) at a wavelength of 570 nm. Cellular morphology study Cellular morphological changes resulting from exposure to ZnO NPs were examined using an inverted microscope (ECLIPSE Ti-S, Nikon, Japan) at 10x magnification. This analysis was conducted at intervals of 24, 48, and 72 h. Furthermore, morphological alterations at 72 h were visualized at a magnification of 2000x using a scanning electron microscope (SEM) (JSM-6701 F, JEOL, Japan). Intracellular ROS assay Intracellular ROS production was assessed using DCFH-DA as outlined by Aralifi et. al21. Cells (1 × 104 per well) were incubated for 24 hours before being treated with varying concentrations of ZnO NPs (1.57 to 100 µg/mL) and 1mM hydrogen peroxide (H2O2) as a positive control for 24, 48, and 72 hours. Post-treatment, cells were rinsed with PBS, and 100 µl of 2’,7’-dichlorodihydrofluorescein diacetate (H2DCF-DA) solution was added. After a 30-minute incubation in the dark at 37 °C with 5% CO2, excess DCFH-DA was removed and replaced with PBS. Fluorescence was measured using a microplate reader (Omega, BMG Labtech, Germany) (excitation: 485 nm, emission: 530 nm) and visualized with an inverted fluorescence microscope (Nikon ECLIPSE Ti-S, Tokyo, Japan). Assessment of lipid peroxidation Lipid peroxidation was evaluated using C11 BODIPY 581/591 dye as outlined by Sheng et al.22. Cells (1 × 104 per well) were incubated for 24 h, then treated with various concentrations of ZnO NPs (1.57 to 100 µg/mL) and 1 mM hydrogen peroxide (H2O2) for 24, 48, and 72 h. After treatment, cells were washed with PBS, and 100 µL of 10 µM C11 BODIPY 581/591 dye solution was added. Following a 30-minute incubation at 37 °C with 5% CO2 in the dark, excess dye was replaced with PBS. Using a microplate reader (Omega, BMG Labtech, Germany) set to 485 nm for excitation and 530 nm for emission, fluorescence was measured and visualized with an inverted fluorescence microscope (ECLIPSE Ti-S, Nikon, Japan). Cell apoptotic study Each well in a 96-well microplate was plated with 100 µL of cell suspension and incubated for 24 h. Samples and positive control were prepared in the concentrations of 100 µg/mL. Plated cells were treated with 100 µL of sample and control and incubated further for 72 h. Apoptotic cell death was quantified via a flouresin isothiocynate (FITC)-conjugated Annexin V/7AAD assay kit by flow cytometry, as described by Zhou et al.23. Cells were washed with PBS and added with 0.25% trypsin-EDTA solution. The cells were spun at 300 g for 5 min and rinsed with PBS again before centrifugation. 500 uL of binding buffer were added along with 5 uL Annexin V-FITC & 7AAD and the cells were analyzed (Attune NxT, Life Technologies, California). Results and discussion Preliminary phytochemical screening A qualitative phytochemical screening was undertaken to ascertain the presence of secondary metabolites in the aqueous extract of stem bark of C. teysmannii. This analysis is pivotal due to the critical role these compounds play in the synthesis of ZnO NPs. The investigation demonstrated that the aqueous fraction of the examined plant extract contained the requisite secondary metabolites such as phenols, saponins, flavonoids, tannins, and coumarins necessary for nanoparticle fabrication. Quinones, however, were absent from the extract (Table 1). Table 1Phytochemical analysis of C. teysmannii stem bark aqueous extract. Note: the “+” symbol indicates the presence of the constituent, while the “−” symbol indicates its absence in the aqueous extract of C. teysmannii stem bark.ConstituentsObservationsResultPhenolSolution turned black+SaponinFoam formation+FlavonoidSolution turned orangish-red+TanninSolution turned black+QuinoneNo colour change-CoumarinSolution turned yellow+ Table 1Phytochemical analysis of C. teysmannii stem bark aqueous extract. Note: the “+” symbol indicates the presence of the constituent, while the “−” symbol indicates its absence in the aqueous extract of C. teysmannii stem bark.ConstituentsObservationsResultPhenolSolution turned black+SaponinFoam formation+FlavonoidSolution turned orangish-red+TanninSolution turned black+QuinoneNo colour change-CoumarinSolution turned yellow+ Phytochemical analysis of C. teysmannii stem bark aqueous extract. Note: the “+” symbol indicates the presence of the constituent, while the “−” symbol indicates its absence in the aqueous extract of C. teysmannii stem bark. Phytochemicals play a crucial role in the synthesis of ZnO NPs by leveraging their intrinsic biochemical properties. According to Al-Darwesh et al.24, plant extracts’ dual roles as capping and reducing agents in nanoparticle production are greatly influenced by the presence of amino acids, alkaloids enzymes, proteins, and polysaccharides. Saponins and phenols contribute to the stabilization of Zn(OH)₂ gel, ensuring the controlled growth and morphology of ZnO NPs by preventing agglomeration and maintaining a uniform nanoscale size25. The attributes of the plant extract, including the types and concentrations of phytochemicals, metal salt concentrations, pH, and temperature, stand as critical factors influencing the rate, yield, and stability of nanoparticle formation26. Moreover, the properties of the ZnO NPs are also influenced by the phytochemicals present in the plant extract. They are essential in regulating the nanoparticles’ size, shape, and crystallinity, which influences their chemical and physical characteristics27. According to Acharya et al.28, biomolecules within these extracts actively regulate the nucleation and growth of nanoparticles, often favouring spherical structures due to balanced kinetics, resulting in uniform and compact nanoparticle formations as illustrated in Fig. 1. Fig. 1Biosynthesis mechanism involved in producing ZnO NPs. Biosynthesis mechanism involved in producing ZnO NPs. Green synthesis of ZnO NPs Fig. 2Illustrates the green synthesis of ZnO NPs using an aqueous extract of C. teysmannii stem bark, reacted with zinc nitrate hexahydrate, followed by centrifugation, washing, and calcination at 400 °C to produce ZnO NPs. Illustrates the green synthesis of ZnO NPs using an aqueous extract of C. teysmannii stem bark, reacted with zinc nitrate hexahydrate, followed by centrifugation, washing, and calcination at 400 °C to produce ZnO NPs. Figure 2 exhibits the green synthesis procedure of ZnO NPs incorporating the aqueous stem bark extract of C. teysmannii. The plant extracts facilitate the creation of nanoparticles by acting as reducing and stabilising agents simultaneously. Additionally, the specific composition of the plant extract significantly impacts nanoparticle synthesis, with different plants containing varying concentrations of these components29–32. The use of phytochemicals thus offers an eco-friendly and sustainable alternative to traditional chemical synthesis methods, reducing reliance on toxic reagents and high-energy processes. Characterization of ZnO NPs UV-Vis spectroscopy The UV-Vis spectrum of the green synthesized ZnO NPs revealed a distinct absorption peak at approximately 372 nm (Fig. 3A). These findings align with the literature, where the typical photo-absorbance range for ZnO NPs has been reported to lie between 330 and 400 nm33. The absorption peak signifies electronic transitions occurring within the band structure of ZnO NPs. By employing the formula E = hν (where E represents the bandgap energy, h is Planck’s constant, and ν is the frequency of light), we determined the bandgap energy to be approximately 3.24 eV (Fig. 3B). This bandgap energy falls within the typical range reported in the literature for ZnO NPs (3.2 to 3.4 eV), indicating successful synthesis consistent with expected properties. These findings are consistent with the data presented by34, where the UV-Vis spectra exhibited a prominent absorption peak around 370 nm, validating the effective formation of ZnO NPs utilizing an aqueous extract of L. pruinosum, while35 reported an absorption peak at about 376 nm with energy bandgap at 3.3 eV for ZnO NPs synthesized using Sambucus ebulus extract. Fig. 3UV spectra of ZnO NPs; (A) absorption peak and (B) bandgap energy. UV spectra of ZnO NPs; (A) absorption peak and (B) bandgap energy. X-Ray diffraction (XRD) The X-ray diffraction (XRD) spectra obtained provided a crucial understanding of the morphological features and crystallinity of the synthesized nanoparticles. As shown in Fig. 4, the observed diffraction peaks are in agreement with the standard diffraction pattern for hexagonal wurtzite ZnO (ICDD card no. 01-075-0576) as reported by36 confirming the successful formation of crystalline ZnO NPs. The prominent diffraction peaks at 2θ values of approximately 31.84°, 34.52°, 36.36°, 47.72°, 56.80°, 63.08°. 66.58°, 68.20°, and 69.20 corresponded to 100, 002, 101, 102, 110, 103, 200, 112 and 201 crystallographic planes of ZnO, respectively. The high intensity and narrow width of these peaks indicated a high degree of crystallinity and preferential orientation along the c-axis, characteristic of well-formed ZnO NPs. The average crystallite size of the green-synthesized ZnO NPs can be estimated using the Scherrer equation, which relates the peak width to the crystallite size. The calculation revealed an average crystallite size of approximately 29.44 nm, consistent with the nanoscale dimensions expected for ZnO NPs. The notable intensity observed at the (101) peak suggested anisotropic growth, indicating a preferred orientation of the crystallites37. Fig. 4XRD spectrum of ZnO NPs. XRD spectrum of ZnO NPs. Field Emission Scanning Electron microscope (FESEM) and Energy Dispersive X-Ray (EDX) The FESEM results provided a comprehensive view of the morphological features of the synthesized ZnO NPs, providing information on size distribution, shape variations, and agglomeration behaviour. The FESEM images showed that the size of the biosynthesized ZnO NPs was ranging from 31.5 to 59.9 nm with spherical-like morphologies (Fig. 5A). The observed size variations can be attributed to the synthesis conditions used, which include precursor concentration, temperature, and reaction time. By fine-tuning these parameters, the size distribution which is essential for tailoring the properties of ZnO NPs can be controlled. In a related study by Sivaraj et al.38, SEM analysis demonstrated that bio-fabricated ZnO NPs exhibited a spherical shape, often appearing in aggregated forms. The results indicated size ranges of the ZnO NPs varying from 50 nm to 80 nm, with an average size estimated at 65 nm. The EDX analysis (Fig. 5B) revealed a comprehensive understanding of the elemental composition present in the ZnO NPs. The major elements, zinc (Zn) and oxygen (O) are expected to be prominent due to the nature of the synthesized material. The elemental analysis of the nanoparticles indicated the presence of 58.01% zinc, 32.89% oxygen, and 9.10% carbon elements. The existence of supplementary elements like carbon (C) can provide valuable indications regarding potential impurities arising during the synthesis process. The presence of carbon is indicative of stabilizing agents derived from the plant extract, which are crucial for the biogenic synthesis process39. Additionally, carbon coating on the sample or carbon inherent in the EDX detector itself might contribute to the observed carbon signal. For instance, in a study by Rasli et al.40, synthesizing ZnO NPs using aloe vera extract, EDX analysis validated the presence of Zn (40.47%), O (47.93%), and N (11.61%). Fig. 5FESEM image of ZnO NPs under 25 890x magnification (A), and EDX (B) graphs of ZnO NPs. FESEM image of ZnO NPs under 25 890x magnification (A), and EDX (B) graphs of ZnO NPs. Fourier Transform Infrared Spectroscopy (FTIR) The FTIR analysis (Fig. 6) was conducted to study the functional groups of the synthesized nanoparticles which unveiled a distinctive peak at approximately 507 cm− 1, signifying the formation of Zn˗O nanostructure stretching. Additionally, a broad band observed at 3427 cm− 1 is ascribed to hydroxyl groups (O-H)41. Furthermore, the identification of the C = O vibration mode at peaks of 1606 cm− 1 suggests its role as a bio-capping agent42. Moreover, vibrational peaks around 3427 and 3421 cm− 1 align with hydroxyl (OH) groups akin to those found at around 3370 cm− 1 in the aqueous extract of C. teysmannii stem bark, likely linked to the existence of phenolic and alcoholic compounds43. These peaks affirm the presence of phytochemicals such as phenols and terpenoids within the plant extract, crucial in the reduction and stabilization of ZnO NPs44. Fig. 6FTIR spectra of ZnO NPs (A) and C. teysmannii stem bark extract (B). FTIR spectra of ZnO NPs (A) and C. teysmannii stem bark extract (B). X-ray Photoelectron Spectroscopy (XPS) The X-ray Photoelectron Spectroscopy (XPS) spectra (Fig. 7) revealed the elemental constituents and surface chemistry of the synthesized nanoparticles. In the XPS analysis, the survey spectrum revealed the presence of two major elements, zinc (Zn) and oxygen (O), which are expected constituents of ZnO NPs. The high-resolution XPS spectra of Zn 2p and O 1s further elucidated the chemical states and bonding environments of these elements. The Zn 2p spectrum exhibited two main peaks at binding energies of approximately 1023.15 eV (Zn 2p3/2) and 1046.98 eV (Zn 2p1/2), indicative of the characteristic binding energies for Zn in ZnO. Additionally, the O 1s spectrum displayed dominant peaks at around 529.77 corresponding to the oxygen in ZnO lattice, consistent with the expected chemical composition. Furthermore, the XPS analysis enabled the identification of surface functional groups and defects on the ZnO NP surface. The O 1s spectrum displayed a minor shoulder peak at a higher binding energy around 531.3 eV, indicating the presence of oxygen-related defects or surface hydroxyl groups. Additionally, findings from research conducted by Muthu et al.8 closely resembled the current data. The presence of Zn2+ was corroborated by the appearance of two peaks at 1021 and 1044 eV in the Zn 2p spectra, designated as Zn 2p3/2 and Zn 2p1/2, respectively. As per the literature, the 23 eV gap between these peaks aligns with the accurate value for the spin-splitting energy separation. Furthermore, the O 1s spectrum exhibited peaks at 530 and 531.5 eV, revealing two distinct oxygen peaks on the sample surface. The 530 eV peak corresponds to ZnO, while the 531.5 eV peaks are associated with chemisorbed oxygen due to the presence of surface hydroxyl groups. Fig. 7XPS spectra of Zn2p (A), O1s (B) and C1s (C) of ZnO NPs. XPS spectra of Zn2p (A), O1s (B) and C1s (C) of ZnO NPs. Raman spectroscopy The Raman spectroscopy analysis was conducted to confirm the structural and surface properties of the synthesized ZnO NPs. As shown in Fig. 8, prominent vibration peaks were revealed at 320, 425, and 580 cm− 1, with the highest intensity observed at 425 cm− 1 corresponding to E2 high. This peak’s sharpness and strength confirm the wurtzite structure of the ZnO NPs45. The peak at 580 cm− 1 is attributed to zinc interstitials or oxygen vacancies46 while the 320 cm− 1 peak is associated with the A1 transverse mode, arising from the material’s anisotropic force constant. These findings align with data previously reported by Khajuria et al.45, where the most intense peak appeared at 435 cm− 1 corresponding to the E2 high. A sharp and robust E2 mode peak around 435 cm− 1 likewise confirmed the wurtzite structure of the ZnO NPs. The 579 cm− 1 peak was linked to oxygen imperfections, and the 380 cm− 1 peak was assigned to the A1 transverse mode due to the material’s anisotropic force constant. Fig. 8Raman spectra of ZnO NPs. Raman spectra of ZnO NPs. Antiproliferative Analysis MTT Assay Nanoparticles hold great promise as anticancer agents, with numerous studies demonstrating that ZnO NPs exhibit significant cytotoxicity against various cancer cell types, surpassing their macro-sized counterparts47. In this study, ZnO NPs showed selective toxicity towards cancer cell lines while being less toxic to normal cells. Cancer cells treated with ZnO NPs exhibited a reduction in viability by more than 50% at a concentration of 100 µg/mL after 24, 48, and 72 h of incubation (Fig. 9). These findings highlight the capacity of ZnO NPs to impede the proliferation of cancer cells based on the dose and duration of exposure. Comparable anticancer effects of biosynthesized ZnO NPs have been previously reported as well48,49. The IC50 values obtained for HCC2998 cells were 30.0, 13.3, and 10.0 µg/mL at 24, 48, and 72 h, respectively (Table 2). Conversely, the viability of the Vero cell line remained above 50% at all incubation times (Fig. 10), with no IC50 value observed, indicating the reduced toxicity of green-synthesized ZnO NPs towards normal cells. A few previous studies50,51 provided additional insights into the cytotoxicity of ZnO NPs on several cell lines, contributing to the understanding of their potential applications and mechanisms of action. For example, ZnO NPs derived from the aqueous leaf extract of Aquilegia pubiflora demonstrated the high cytotoxicity on the HepG2 cell line47. The decrease in cell viability of 23.68% following 24 h of incubation signifies a substantial effect on cell survival. This finding supports the notion that ZnO NPs can exert potent cytotoxic effects on specific cancer cell lines, further highlighting their potential as therapeutic agents. Similarly, significant cytotoxicity was shown by ZnO NPs synthesized with the leaf extract of Azadirachta indica against SiHa cervical cancer cell lines51. The findings from this study indicate a clear relationship between the impact of ZnO NPs on cell viability and the dosage and duration of exposure across various cell lines. A significant decrease in cell viability was observed with increasing concentrations of ZnO NPs. Furthermore, the duration of exposure played a crucial role, with longer exposure periods (particularly at 48 and 72 h) resulting in more pronounced reductions in cell viability compared to shorter exposures (24 h). This trend indicates that the cytotoxic effects of ZnO NPs intensify over time, emphasizing the importance of considering exposure duration in potential therapeutic applications. Additionally, the study highlights the targeted cytotoxicity of ZnO NPs, as evidenced by the significantly higher percentage of cell viability in Vero cells compared to HCC2998 cells. This targeted effect suggests that ZnO NPs may have potential as a selective therapy against cancer cells while sparing healthy cells. Moreover, the cytotoxicity of ZnO NPs is vastly influenced by culturing conditions, the size and surface charge of ZnO NPs7,52. Zinc is a vital mineral that helps maintain body balance by regulating enzyme activities. It is critical in regulating the tumor suppressor gene p53 and activating the caspase-6 enzyme to modulate apoptosis. Moreover, ZnO NPs possess unique electrostatic properties that allow for selective targeting of cancer cells53. This targeting is driven by the presence of anionic phospholipids on cancer cell surfaces, which attract ZnO NPs, leading to their uptake and resulting in cytotoxicity. Due to their nano size, ZnO NPs efficiently penetrate and stay within tumor cells, demonstrating their therapeutic effects54,55. The internalization of ZnO NPs by cells plays a crucial role in their cytotoxicity as once internalized, the nanoparticles interact directly with cellular components, causing severe structural damage through the release of Zn ions and the generation of reactive oxygen species (ROS) such as superoxide anion (O2−) and hydroxyl radicals (OH∙) and ultimately leading to cell death56. According to Sabella et al.57, this cytotoxic effect, referred to as the “lysosome-enhanced Trojan horse effect,” is caused by the dissolution of ZnO NPs. Fig. 9Percentage of cell viability of HCC2998 cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Percentage of cell viability of HCC2998 cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Fig. 10Percentage of cell viability of Vero cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Percentage of cell viability of Vero cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Table 2Summary of IC50 (µg/mL) of samples at 24, 48 and 72 h incubation.Cell lineHCC2998VEROIncubation hours (h)24 h48 h72 h24 h48 h72 hIC50 (µg/mL)ZnO NPs30.0 ± 9.213.3 ± 5.510.0 ± 4.0> 100> 100> 100Positive control8.0 ± 1.76.3 ± 2.53.9 ± 1.06.3 ± 2.53.7 ± 0.62.1 ± 0.4 Table 2Summary of IC50 (µg/mL) of samples at 24, 48 and 72 h incubation.Cell lineHCC2998VEROIncubation hours (h)24 h48 h72 h24 h48 h72 hIC50 (µg/mL)ZnO NPs30.0 ± 9.213.3 ± 5.510.0 ± 4.0> 100> 100> 100Positive control8.0 ± 1.76.3 ± 2.53.9 ± 1.06.3 ± 2.53.7 ± 0.62.1 ± 0.4 Summary of IC50 (µg/mL) of samples at 24, 48 and 72 h incubation. Cellular morphology study Exposure of HCC2998 cells to ZnO NPs induces significant morphological changes over time. After 24 h of treatment, cells begin to show signs of stress, including a reduction in cell size and the appearance of irregular shapes. Anchorage-dependent cancer cells undergo a loss of adhesion to their substrate, causing them to become rounded and subsequently shrink due to cell death58,59 while control cells maintain a normal morphology with regular shapes and intact cell membranes. By 48 h, these changes become more pronounced, with many cells exhibiting detachment from the substrate, increased granularity, and membrane blebbing, indicating the onset of apoptosis. At the 72-hour mark, a substantial number of cells undergo cell death, characterized by extensive cell shrinkage, loss of membrane integrity, and the presence of apoptotic bodies which appeared to be more prominent under a scanning electron microscope, whereas control cells remain largely unaffected (Figs. 11 and 12). These morphological alterations suggested that ZnO NPs effectively inhibit cell proliferation and promote apoptosis in HCC2998 cells over time. These findings were similar to the study conducted by Kc et al.60, whereby ZnO NPs manifested concentration-dependent cytotoxicity on MDA-MB-231 cells with significant changes in cancer cell morphology such as cell shrinkage, detachment, and membrane blebbing. Additionally61, noted that treatment with ZnO NPs resulted in dose-dependent alterations in cell morphology, including detachment, reduction of cell size, membrane blebbing, and distortions in MDA-MB-231 cells. In contrast, control cells exhibited healthy and intact cell morphology. On the other hand, upon exposure to ZnO NPs, Vero cells exhibit subtle but progressive morphological changes over time compared to control cells. After 24 h of treatment, Vero cells show minimal alterations, maintaining their characteristic elongated shape and intact membrane similar to the control cells, which remain unaffected. At the 48-hour mark, slight morphological changes become more noticeable in treated cells, such as a mild increase in granularity and occasional membrane blebbing, while control cells continue to display normal morphology without any signs of stress. By 72 h, the treated Vero cells exhibit more pronounced changes, including moderate cell shrinkage, increased granularity, and more frequent membrane blebbing, indicating heightened cellular stress. However, these changes are less extreme compared to those observed in cancer cells under similar treatment conditions. Control Vero cells at 72 h still show healthy morphology, underscoring the relatively mild impact of biogenic ZnO NPs on non-cancerous cells compared to their more severe effects on cancer cells (Figs. 11 and 12). Fig. 11Analysis of ZnO NPs-induced cytotoxicity on the morphological alterations of HCC2998 and Vero cell lines under inverted microscope (10x). Analysis of ZnO NPs-induced cytotoxicity on the morphological alterations of HCC2998 and Vero cell lines under inverted microscope (10x). Fig. 12Analysis of ZnO NPs-induced cytotoxicity on the morphological alterations of HCC2998 and Vero cell lines under scanning electron microscope (2Kx). Analysis of ZnO NPs-induced cytotoxicity on the morphological alterations of HCC2998 and Vero cell lines under scanning electron microscope (2Kx). ROS assay A sequential increase in ROS levels was observed in HCC2998 cells following exposure to ZnO NPs at various concentrations for 24, 48, and 72 h. The data, illustrated in Fig. 13 and supported by images in Fig. 15, show a clear dose- and time-dependent increase in ROS generation compared to control cells. Specifically, in HCC2998 cells, ROS levels at the highest concentration of 100 µg/mL were 176.6%, 199.3%, and 221.4% at 24, 48, and 72 h, respectively. In contrast, as shown in Figs. 14 and 15, Vero cells exhibited significantly lower ROS levels under the same conditions, with percentages recorded at 103.9%, 114.1%, and 119.4% at 24, 48, and 72 h, respectively. Although Vero cells are non-cancerous and generally less susceptible to oxidative stress than cancer cells, ZnO NPs still induce a measurable amount of ROS, resulting in detectable fluorescence. This indicates the occurrence of oxidative stress, albeit to a lesser extent compared to cancer cells, reflecting the different sensitivities of Vero and HCC2998 cells to nanoparticle exposure. This differential ROS generation suggests that ZnO NPs could be effectively utilized to target cancer cells while minimizing damage to normal cells, provided that the concentration and exposure duration are carefully controlled. There is a clear dose-dependant and time-dependent relationship between nanoparticle concentration and ROS levels. A significant increase in ROS production is observed with higher nanoparticle concentrations. This ROS generation intensifies as the incubation period extends from 24 to 48 h and then to 72 h, with fluorescence intensity increasing over time. In contrast, untreated cells show very minimal fluorescence. These findings were also in agreement with the previous study done by61, in which a substantial concentration-dependent rise in intracellular ROS production upon exposure to ZnO NPs treatment was observed in MDA-MB-231 and another study using human multiple myeloma cells62. Although intracellular ROS are essential for cell development and differentiation, exceeding a certain threshold level leads to irreversible damage in numerous cellular processes. This continued accumulation ultimately results in cell death63. ZnO NPs induce oxidative stress by elevating ROS production within cells. Previous research has indicated a decrease in antioxidant enzymes like GSH and SOD following oral exposure to ZnO NPs in rodent models, underscoring an escalation in ROS levels64. Moreover, the excessive generation of ROS can trigger dysfunctions in the endoplasmic reticulum, leading to cell death65. These generalized mechanisms elucidate the ROS-dependent oxidative stress pathway that culminates in apoptosis. Research by66 showcased the proapoptotic effects of ZnO NPs through the induction of ROS generation and consequently oxidative stress in human ovarian cancer cells. These current findings align with earlier studies highlighting increased ROS production as a primary cytotoxic mechanism of ZnO NPs. Fig. 13Percentage of reactive oxygen species generation from HCC2998 cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Percentage of reactive oxygen species generation from HCC2998 cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Fig. 14Percentage of reactive oxygen species generation from Vero cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Percentage of reactive oxygen species generation from Vero cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Fig. 15Visualization of intracellular ROS dynamics of HCC2998 and Vero cell lines upon exposure to ZnO NPs via fluorescence microscopy (10x) at three time points (24 h, 48 h, and 72 h), with control, ZnO NPs-treated, and H₂O₂-treated cells. In both cell lines, the control group (left column) exhibits minimal fluorescence across all time points, indicative of low basal levels of ROS and negligible cytotoxicity. In contrast, the ZnO NPs-treated group (middle column) demonstrates a marked, time-dependent increase in fluorescence intensity, particularly evident at 48 and 72 h for the HCC2998 cells. This indicates a significant escalation in ROS production, which correlates with enhanced oxidative stress and cellular damage. The highest fluorescence intensity at 72 h suggests substantial ROS accumulation and resultant cell death. The positive control group, treated with H₂O₂ (right column), shows high fluorescence from 24 h onwards, confirming robust ROS generation and extensive oxidative damage. Visualization of intracellular ROS dynamics of HCC2998 and Vero cell lines upon exposure to ZnO NPs via fluorescence microscopy (10x) at three time points (24 h, 48 h, and 72 h), with control, ZnO NPs-treated, and H₂O₂-treated cells. In both cell lines, the control group (left column) exhibits minimal fluorescence across all time points, indicative of low basal levels of ROS and negligible cytotoxicity. In contrast, the ZnO NPs-treated group (middle column) demonstrates a marked, time-dependent increase in fluorescence intensity, particularly evident at 48 and 72 h for the HCC2998 cells. This indicates a significant escalation in ROS production, which correlates with enhanced oxidative stress and cellular damage. The highest fluorescence intensity at 72 h suggests substantial ROS accumulation and resultant cell death. The positive control group, treated with H₂O₂ (right column), shows high fluorescence from 24 h onwards, confirming robust ROS generation and extensive oxidative damage. BODIPY assay Lipid peroxidation, a key indicator of oxidative stress and cell membrane damage, was evaluated in HCC2998 and Vero cells after treatment with ZnO NPs at varying concentrations of ZnO NPs over incubation periods of 24, 48, and 72 h. The oxidation of fatty acids results in the formation of lipid peroxides, which initiate a chain reaction that disrupts the integrity of plasma and organelle membranes, ultimately leading to cell death67. The C11 BODIPY 581/591 dye used in this study fluoresces differently upon oxidation, allowing for quantitative (Figs. 16 and 17) and qualitative (Fig. 18) analysis of lipid peroxidation through changes in fluorescence intensity. This assay is particularly useful for assessing the oxidative stress potential of various treatments on different cell types. ZnO NPs are known for their photocatalytic properties and ability to generate ROS, which can induce oxidative stress in cells. HCC2998 cells exhibited a high level of lipid peroxidation upon exposure to ZnO NPs, especially at higher concentrations and longer incubation periods. In the highest concentration, the percentage of lipid peroxidation recorded was 148.9%, 158.7%, and 190.4% at 24, 48, and 72 h respectively. The increased oxidative stress may be attributed to the elevated metabolic activity and intrinsic oxidative stress within cancer cells, making them more vulnerable to ROS generated by ZnO NPs. The findings were comparable to the findings reported by Motafeghi et al.68 whereby exposure of HT29 and PC3 cells to ZnO NPs induces the production of ROS and depletes intracellular glutathione. This occurs through the disruption and impairment of mitochondrial function, leading to elevated ROS levels and consequent lipid membrane damage. Notably, these effects are dose-dependent. In another study by Akhtar et. al69, ZnO NPs elevate oxidant levels, specifically ROS and lipid peroxidation, while concurrently diminishing the antioxidant capacity within HepG2 cells. This data indicates that ZnO NPs promote apoptosis in cancer cells, primarily driven by ROS. This apoptotic mechanism involves key molecular pathways, including p53, Bax/Bcl-2, and caspases, which are commonly targeted by numerous anticancer agents to induce cell death. In contrast, Vero cells demonstrated lower levels of lipid peroxidation across all concentrations and time points. The peak lipid peroxidation level observed at 72 h was 143.5%, which is approximately 20% lower than the maximum values recorded for the other two cancer cell lines. This substantial difference underscores the comparatively enhanced resilience of non-cancerous Vero cells to oxidative stress induced by ZnO NPs, highlighting the potential for selective cytotoxicity towards cancer cells. As non-cancerous cells, Vero cells have more robust antioxidant defenses and lower basal ROS levels, which may contribute to their reduced susceptibility to oxidative stress induced by ZnO NPs. This differential response highlights the importance of targeted delivery and dosage optimization in potential therapeutic applications to minimize damage to healthy cells. The primary mechanism through which ZnO NPs induce lipid peroxidation is via ROS generation70. Upon cellular uptake, ZnO NPs can interact with intracellular components and disrupt the redox balance, progressing to elevated ROS production. This oxidative stress overwhelms cellular antioxidant defenses, exerting lipids, proteins, and DNA damage. The observed differential susceptibility among cell types can be explained by the inherent oxidative stress levels and antioxidant capacities of the cells. Fig. 16Percentage of lipid peroxidation from HCC2998 cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Percentage of lipid peroxidation from HCC2998 cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Fig. 17Percentage of lipid peroxidation from Vero cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Percentage of lipid peroxidation from Vero cell line following 24, 48 and 72 h incubation. The bars depict the mean ± standard deviation (n = 3) and * denotes the significant differences (p < 0.05) between the control and treated cells. Fig. 18Fluorescence microscopy at 10x magnification capturing cellular staining of HCC2998 and Vero cells with C11-BODIPY 581/591 probe following ZnO NPs exposure. Fluorescence microscopy at 10x magnification capturing cellular staining of HCC2998 and Vero cells with C11-BODIPY 581/591 probe following ZnO NPs exposure. ZnO NPs Induced apoptosis in Cancer cells In the HCC2998 cells, a substantial increase in cell death was observed in the late apoptosis phase after 72 h of treatment with biogenic ZnO NPs. This suggests that the nanoparticles induced significant cell apoptosis in cancer cells. However, in Vero cells, while cell death was also observed, it was less pronounced compared to the cancer cell lines, indicating a differential cytotoxic response between normal and cancerous cells (Fig. 19). In a previous study by Moghaddam et al.71, ZnO NPs were reported to induce early apoptosis rather than necrosis pathway. The presence of HCC2998 cells in the S phase of the cell cycle following treatment with ZnO NPs suggests that these nanoparticles may induce DNA damage and trigger cell cycle checkpoints. Cells experiencing DNA damage often temporarily arrest in the S phase to facilitate accurate DNA repair before progressing through the cell cycle72. ZnO NPs can also induce cellular stress responses, activating checkpoints that delay cell cycle progression, potentially causing an increase in the number of cells in the S phase. Additionally, ZnO NPs may affect specific cell cycle regulation mechanisms or induce apoptosis in a portion of the cell population, leading to an enrichment of cells in the S phase among the surviving population. The presence of Vero cells in the G1 phase of the cell cycle following treatment with ZnO NPs may result from the activation of cell cycle checkpoints and the induction of cellular stress by these nanoparticles (Fig. 19). ZnO NPs could trigger the G1 checkpoint, temporarily halting cell cycle progression to allow for DNA damage assessment or repair, especially if the NPs induce cellular stress responses. Additionally, ZnO NPs might lead to cellular toxicity and apoptosis, preventing cells from progressing beyond the G1 phase. Specific interactions with cell cycle regulatory mechanisms could also contribute to this observation. Fig. 19Flow cytometric Annexin-V/7-AAD binding profiles (left) and cell cycle arrest profiles (right) of (A) HCC2998 and (B) Vero treated with (i) biogenic ZnO NPs, (ii) positive control (doxorubicin/DMSO) and (iii) negative control after 72 h incubation. Flow cytometric Annexin-V/7-AAD binding profiles (left) and cell cycle arrest profiles (right) of (A) HCC2998 and (B) Vero treated with (i) biogenic ZnO NPs, (ii) positive control (doxorubicin/DMSO) and (iii) negative control after 72 h incubation. Fig. 20Schematic depiction of potential cytotoxic mechanisms induced by ZnO NPs. Schematic depiction of potential cytotoxic mechanisms induced by ZnO NPs. The anticancer activity of green synthesized ZnO NPs is multifaceted, involving several mechanisms that collectively contribute to their cytotoxic effects on cancer cells. The proposed mechanism of the anticancer action of the biogenic ZnO NPs is illustrated as shown in Fig. 20. These nanoparticles dissolve rapidly in the acidic intracellular environment of cancer cells, releasing zinc ions (Zn²⁺) that induce oxidative stress by generating ROS73. This increased ROS production leads to mitochondrial dysfunction and activation of the intrinsic mitochondrial apoptotic pathway74, ultimately causing damage to cancer cells. Conclusion This study has successfully synthesized ZnO NPs using an aqueous extract from C. teysmannii stem bark, marking a novel approach in nanoparticle synthesis. The ZnO NPs, had sizes ranging from 31.5 to 59.9 nm, with spherical morphologies as revealed by XRD and SEM analyses. EDX and FTIR confirmed their elemental composition and the presence of functional groups, respectively. The optical properties, as determined by UV-Vis spectroscopy, showed characteristic absorption in the UV range at 372 nm with a band gap of 3.24 eV, further validating the successful synthesis. XPS and Raman spectroscopy further verified the ZnO NPs’ wurtzite structure. The ZnO NPs exhibited potent cytotoxic activity against HCC2998 colon cancer cells, with IC50 values decreasing from 30.0 µg/mL at 24 h to 10.0 µg/mL at 72 h, demonstrating time-dependent efficacy. Notably, the Vero cell line retained over 50% viability across all time points, with no observable IC50. The morphological changes observed through inverted, and FESEM microscopy revealed characteristic apoptotic features, such as membrane blebbing and cell shrinkage, providing further confirmation of the nanoparticles’ effectiveness. The preservation of normal cell morphology in Vero cells suggests a higher therapeutic index for these plant-mediated ZnO NPs, which is crucial for cancer treatment. The ROS and lipid peroxidation analysis demonstrated a dose- and time-dependent increase in oxidative stress, further corroborating cell apoptosis. The observed cytotoxicity suggests that the ZnO NPs rapidly dissolve in the acidic microenvironment of cancer cells, leading to a pronounced surge in ROS generation. This elevated ROS production disrupts mitochondrial function, resulting in oxidative stress, lipid peroxidation, and the activation of apoptotic pathways. These findings underscore the selective targeting of cancer cells by the nanoparticles, validating their efficacy in inducing cytotoxic effects through oxidative damage and apoptosis. Overall, these findings suggest that C. teysmannii-derived ZnO NPs hold promise as a selective anticancer agent, meriting further in vivo investigation.